Skip to main content
ACoP 2024 Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Mark Lovern, PhD (he/him/his)

Chief Platform Officer
InSilicoTrials
RALEIGH, North Carolina, United States

Mark Lovern, Ph. D.
Dr Mark Lovern is the Chief Platform Officer for InSilicoTrials, and has 25+ years of experience in the
application of model-informed drug development (MIDD). Throughout his career, Mark has led and
contributed to numerous projects involving quantitative pharmacology. Prior to his present position,
Mark spent over 10 years at Certara in a variety of capacities. His work history has been split between
biopharmaceutical companies (GSK and UCB) and companies that support the biopharmaceutical
industry (Quintiles and Certara.) In addition to modeling pharmacokinetic and pharmacodynamic data
across a wide variety of compounds and therapeutic areas, Mark has also taught over 50 technical
training workshops on modeling tools and methodology. His most recent therapeutic area experience
has been with therapies for infectious disease, metabolic, and autoimmune disorders.
Mark was awarded a Ph. D. in Biomathematics from North Carolina State University in 1997. His favorite
leisure activities include hosting dinner parties, traveling, reading, and enjoying films.

Disclosure(s): No financial relationships to disclose

Presentation(s):

Email Mark